Gelesis Holdings Stock (NYSE: GLS)
|Day Range1.04 - 1.14||52 Wk Range1.01 - 8.24||Open / Close1.08 / 1.13||Float / Outstanding20M / 72.9M|
|Vol / Avg.27.9K / 112.6K||Mkt Cap81.3M||P/E-||50d Avg. Price1.29|
|Div / Yield-||Payout Ratio-||Total Float20M||EPS-0.17|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Gelesis Holdings (NYSE: GLS) through any online brokerage.
The latest price target for Gelesis Holdings (NYSE: GLS) was reported by Citigroup on Tuesday, September 20, 2022. The analyst firm set a price target for 1.15 expecting GLS to rise to within 12 months (a possible 3.14% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Gelesis Holdings (NYSE: GLS) is $1.115 last updated September 28, 2022, 7:59 PM UTC.
There are no upcoming dividends for Gelesis Holdings.
Gelesis Holdings’s Q3 earnings are confirmed for Friday, November 18, 2022.
There is no upcoming split for Gelesis Holdings.
Gelesis Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.